CuraGen Corp. subsidiary 454 Life Sciences, a Branford, Conn.-based developer of genome-scale sequencing technologies, today announced that it has obtained an exclusive license for sole use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback